Symposium of AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers

*Yasuhiro Kato^1,6,12, Yuta Yamaguchi^1,5,6,17,12, Saori Amiya^1,3,6,7,12, Shoichiro Inokuchi², Sayaka Nagao³, Kazuma Kosaka^1,6, Shinichiro Nameki^1,6,8, Teruaki Murakami^1,6,9, Yuko Yoshimine^1,6, Yasutaka Okita^1,6, Takahiro Kawasaki^1,6,10, Takayoshi Morita^1,11, Kohei Tsujimoto^1,6,12, Jun Fujimoto⁴, Masayuki Nishide^1,6, Sumiyuki Nishida^1,12,13, Masashi Narazaki^1,14, Atsushi Kumanogoh^{1,3,6,12,15,16} (1. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka (Japan), 2. Real World Evidence Division, Pharmaceutical Business Unit, JMDC Inc. (Japan), 3. Center for Infectious Diseases for Education and Research (CiDER), The University of Osaka (Japan), 4. Department of Clinical Immunology, Osaka International Medical & Science Center, (Japan), 5. Division of Pharmacology, Graduate School of Medicine, Kobe University (Japan), 6. Department of Immunopathology, World Premier International Research Center Initiative (WPI), Immunology Frontier Research Center (IFReC), The University of Osaka (Japan), 7. Department of Respiratory Medicine, Ikeda City Hospital (Japan), 8. Division of Rheumatology and Allergy, Osaka General Medical Center (Japan), 9. Department of Respiratory Medicine and Clinical Immunology, Nippon Life Hospital (Japan), 10. Division of Rheumatology and Clinical Immunology, University of Pittsburgh (USA), 11. The Center for Rheumatic Disease, Nara Medical University (Japan), 12. Center for Advanced Modalities and Drug Delivery Systems (CAMaD), The University of Osaka (Japan), 13. Strategic Global Partnership & X (Cross)-Innovation Initiative, Graduate School of Medicine, The University of Osaka and The University of Osaka Hospital (Japan), 14. Department of Advanced Clinical and Translational Immunology, Graduate School of Medicine, The University of Osaka (Japan), 15. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), The University of Osaka (Japan), 16. Japan Agency for Medical Research and Development – Core Research for Evolutional Science and Technology (AMED–CREST), The University of Osaka (Japan), 17. Department of Pharmacology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo (Japan))

*Kazuto Yoshimi¹, Rika Hirano¹, Tomoji Mashimo¹ (1. Institute of Medical Science, The University of Tokyo (Japan))

*Yuyo Ka¹, Motohito Goto¹, Riichi Takahashi¹, Nobuhito Hayashimoto¹, Makoto Suematsu¹ (1. Central Institute for Experimental Medicine and Life Science (Japan))

*Tadaki Suzuki¹ (1. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan))

*Hiroki Hayashi¹, Satoshi Baba^1,2, Hironori Nakagami¹ (1. Department of Health Development and Medicine, Graduate School of Medicine, The University of Osaka (Japan), 2. Department of Geriatric and General Medicine, Graduate School of Medicine, The University of Osaka (Japan))

*Mya Myat Ngwe Tun^1,2,3,4, Chia Hsien Wu⁵, Yasuna Nakamura⁵, Jean Claude Balingit¹, Nguyen Thi Thanh Ngan¹, Muhareva Raekiansyah¹, Yuko Nariai³, Yuki Takamatsu², Takeshi Urano³, Tsuyoshi Inoue⁵, Kouichi Morita^1,2,3,4 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University (Japan), 3. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 4. DEJIMA Infectious Diseases Research Alliance, Nagasaki University (Japan), 5. Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University (Japan))

*Kazuhito Tabata¹ (1. Research Institute of Planetary Health, The University of Tokyo (Japan))

*GABRIEL GONZALEZ¹ (1. Institute for Vaccine Research and Development, Hokkaido University (Japan))